Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome

Title: Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome

Volume: 6 Issue: 1

Author(s): Gerard Espinosa and Ricard Cervera

Affiliation:

Keywords: Antiphospholipid syndrome, pulmonary, cardiac, thrombosis

Abstract: Antiphospholipid syndrome is an autoimmune disorder characterized by the presence of antiphospholipid antibodies, hypercoagulability leading to vascular thrombosis, and recurrent fetal loss. Since its recognition, a great number of cardiac manifestations have been reported in association with these antibodies: valvular disease, coronary artery disease, cardiomyopathy and intracardiac thrombosis. Pulmonary manifestations may be associated with this syndrome in both the primary and secondary forms including pulmonary embolism and infarction, pulmonary hypertension, acute respiratory distress syndrome, intraalveolar hemorrhage, primary thrombosis of lung vessels, both large and small, as well as pulmonary capillaritis. In the present chapter we shall focus on the main cardiac and pulmonary features related to the presence of aPL which may be of interest to clinicians.

Cite this article as:

Espinosa Gerard and Cervera Ricard, Cardiac and Pulmonary Manifestations in the Antiphospholipid Syndrome, Current Rheumatology Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339710790827696

DOI https://dx.doi.org/10.2174/157339710790827696	Print ISSN 1573-3971
Publisher Name Bentham Science Publisher	Online ISSN 1875-6360